RXI Pharmaceuticals Corporation (NASDAQ:RXII)
Q3 2016 Earnings Conference Call
November 10, 2016 4:30 PM ET
Executives
Tamara McGrillen - Investor Relations
Dr. Geert Cauwenbergh - Chief Development Officer
Dr. Pamela Pavco - President & Chief Executive Officer
Caitlin Kontulis - Principal Accounting Officer
Analysts
Operator
Good afternoon ladies and gentlemen, and welcome to the RXi Pharmaceuticals’ Third Quarter 2016 Earnings Conference Call. Today’s call is being recorded.